Flow-injection inhibition chemiluminescence determination of indapamide based on luminol-ferricyanide reaction.
J Pharm Biomed Anal
; 35(1): 1-7, 2004 Apr 01.
Article
in En
| MEDLINE
| ID: mdl-15030874
ABSTRACT
A novel and sensitive chemiluminescence (CL) method for the determination of indapamide coupled with flow-injection analysis (FIA) technique is developed in this paper. It is based on the inhibition effect of the studied drug on the chemiluminescence emission of luminol-potassium ferricyanide system. Under the optimum conditions, the decreased CL intensity is proportional with the concentration of indapamide in the range of 1 x 10(-8) to 1.0 x 10(-6) g ml(-1). The detection limit is 3.4 x 10(-9) g ml(-1) (3sigma). A complete analysis could be performed in 45 s including washing and sampling, giving a throughout of about 90 h(-1). The relative standard deviation (R.S.D.) for 11 parallel measurements of 1.0 x 10(-7) g ml(-1) indapamide is 3.0%. The proposed method has been applied for the determination of indapamide in its pharmaceutical formulations. The results obtained compared well with those by an official method. The possible inhibition mechanism of indapamide on luminol-potassium ferricyanide CL system was discussed briefly.
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Flow Injection Analysis
/
Ferricyanides
/
Indapamide
/
Luminol
/
Antihypertensive Agents
Type of study:
Diagnostic_studies
Language:
En
Journal:
J Pharm Biomed Anal
Year:
2004
Document type:
Article
Affiliation country:
China